TP53 and lung carcinoma: Moreover, the reactivation of p53 cannot restrain the MCT-1 tumorigenic impacts on H1299 (p53 null) lung cancer cells xenografted mice and the stimulation of p53 repressors (MDM2, Pirh2, and Cop1).